BioSpace News Archive

Business

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

NeoGenomics, Inc. today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.

June 29, 2023
·
5 min read
Business

Antibe Reports 2023 Year-End Results and Business Highlights

Antibe Therapeutics Inc. has filed its financial and operating results for the fiscal year ended March 31, 2023.

June 29, 2023
·
6 min read
Business

Emergex Appoints Sir Michael Rake as Board Chairman

Emergex Vaccines Holding Limited, a clinical-stage biotechnology company addressing major global infectious diseases through the development of fully synthetic T cell-priming immune set-point candidates, announced the appointment of Sir Michael Rake as Chairman of the Board.

June 29, 2023
·
4 min read
Business

Integer Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023

Integer Holdings Corporation announced that it plans to release financial and operational results for second quarter 2023, at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, July 27, 2023.

June 29, 2023
·
1 min read
China Medical System Included in the First ‘Sustainability Yearbook (China)’ of S&P Global

Recently, S&P Global, the world’s leading corporate sustainability assessment institution, has officially released the first “Sustainability Yearbook 2023 ".

June 29, 2023
·
3 min read
Drug Development

Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August

Cingulate Inc. today announced it has successfully manufactured the clinical supply for upcoming pivotal Phase 3 trials of its lead candidate, CTx-1301 (dexmethylphenidate), for the treatment of attention deficit/hyperactivity.

June 29, 2023
·
6 min read
Business

Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea

ProPhase Labs, Inc. today announced that it recently made an unsolicited offer to acquire certain assets from NYSE American listed Navidea Biopharmaceuticals, Inc. (“Navidea”), and that the offer was rejected by Navidea.

June 29, 2023
·
3 min read
XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Therapeutics Inc. is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held Wednesday, June 28, 2023.

June 29, 2023
·
4 min read
BioForest

Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

Eurofins Genomics Blue Heron is thrilled to announce the launch of our cutting-edge IVT mRNA Synthesis Service.

June 29, 2023
·
3 min read
Drug Development

IntraBio NPC Phase III Successful Trial

IntraBio Announces Positive Pivotal Trial Results of IB1001 for the Treatment of Niemann-Pick Disease Type C Phase 3 trial met the primary endpoint and key secondary endpoints showing high statistical significance.

June 29, 2023
·
5 min read